Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
<h4>Background</h4>To determine if oral metronidazole (MTZ-400 mg bid) with 2% vaginal clindamycin-cream (Clind) or a Lactobacillus acidophilus vaginal-probiotic containing oestriol (Prob) reduces 6-month bacterial vaginosis (BV) recurrence.<h4>Methods</h4>Double-blind placeb...
Saved in:
Main Authors: | Catriona S Bradshaw, Marie Pirotta, Deborah De Guingand, Jane S Hocking, Anna N Morton, Suzanne M Garland, Glenda Fehler, Andrea Morrow, Sandra Walker, Lenka A Vodstrcil, Christopher K Fairley |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/129dfec1378a4de18c32ec55d5594e9c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis
by: Zhi-Luo Deng, et al.
Published: (2018) -
The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review
by: Larissa K. Ratten, et al.
Published: (2021) -
A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis
by: Erica L. Plummer, et al.
Published: (2021) -
Associations between vaginal pathogenic community and bacterial vaginosis in Chinese reproductive-age women.
by: Zongxin Ling, et al.
Published: (2013) -
Acceptability and efficacy of vaginal self-sampling for genital infection and bacterial vaginosis: A cross-sectional study.
by: Claire Camus, et al.
Published: (2021)